Believe it or not, there's something worse than male pattern baldness. It's depression, plunging libido and shrinking genitals. Those are the symptoms doct ...

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing hair-loss ...

Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late. Shares of the ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

The second group, so-called "Constrained Losers," are those hard-to-short stocks that have lost the most over the trailing year. The professors found that these stocks also lag the market, but for a ...

Hims and other telehealth companies make finasteride easy to get and don’t have to disclose side effects in ads.

RKLX, the Defiance Daily Target 2X Long RKLB ETF, seeks daily investment results that correspond to twice (200%) the daily percentage change of Rocket Lab, a company at the forefront of satellite ...

Meet 10 trailblazing Black women breaking barriers and driving change across sports, business, healthcare, and leadership.

Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operation | Hims & Hers ...

The brand, which entered Target just two years ago, will no longer accept orders on its website after March 24.

Roller-coaster healthcare stock Hims & Hers Health (NYSE: HIMS), whose stock got devastated last week by worries that it ...